Tempus AI (TEM) Stock Jumps 7% Following Strong Earnings Despite Executive Stock Sales
Tempus AI (TEM) shares rose 7% to $82.24 after reporting Q3 revenue of $382.49M, up 22% YoY, and an adjusted loss of $0.04 per share, beating estimates. CEO Eric Lefkofsky sold 250,000 shares for $19.4M. Analysts have mixed views, with a consensus Hold rating and an average target of $69.63.
How this was made
The 30-second read
Why it matters
The earnings beat and insider sales created a short‑term price move but add little new information beyond the already‑public filing.
Market read
The article recaps previously released earnings; traders gain minimal actionable insight.
What to watch
Potential upcoming guidance or product updates not covered in the article.
Background
Tempus AI reported Q2 results with revenue up 22% YoY and a narrower loss, followed by a 7% share jump and multiple insider sales under 10b5‑1 plans.
Ticker impact
Tempus AI shares rose ~7% to $82.24 after reporting quarterly earnings and insider stock sales.
Potential pull‑back as the rally may be exhausted; watch for support around $78.
The move is based on already‑public earnings; the insider sales could temper upside.
Market effects
Highlights continued volatility in healthcare‑tech stocks after earnings releases.
U.S. market focus; no broader regional effect.
Limited to investors tracking precision‑medicine equities.
Counterpoint
The 7% rally may be overstated given sizable insider sell‑offs.
Key entities
- companyTempus AI, Inc.
Healthcare‑tech firm focused on precision medicine.
- executiveEric Lefkofsky
CEO who sold 250,000 shares via 10b5‑1 plan.
